Register entry

Zoetis Inc

Data as of · How to read this entry

Registered sites
11
Active NDC listings
29
Live patents
0
Countries
6
Base
United States
Authorisation

Registered operations

Analytical testing8Active ingredient (API) manufacture6Labelling8Finished drug manufacture7Packaging9particle size reduction1Relabelling4Repackaging4sterilize3
Sites

Registered establishments

11
EstablishmentAddressRegistered forFEI / DUNS
Jurox Pty. LimitedRegistrant: Zoetis Inc85 Gardiner Street, Rutherford, NSW 2320, Australia (AUS)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize3003483729751438037
Zoetis Belgium S.A.Registrant: Zoetis IncRue Laid Burniat 1, Ottignies-Louvain-la-Neuve, Louvain-la-Neuve B1348, Belgium (BEL)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize3010087842370053142
Zoetis Manufacturing & Research Spain, S.L.Registrant: Zoetis IncCarretera de Camprodon (L'hostal nou de Bianya), La Vall De, Bianya, Gerona 17813, Spain (ESP)Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize3001748505460052343
ZOETIS BELGIUM S.ARegistrant: Zoetis IncThe Copse, RATHDRUM, , Ireland (IRL)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture, particle size reduction3015422006986062452
Zoetis Belgium S.a.Registrant: Zoetis IncSragh Technology Park, Tullamore, Co. Offaly , Ireland (IRL)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3015596301986062582
Zoetis Manufacturing Italia SRLRegistrant: Zoetis IncVia Gorgone Franco S.N.C., CATANIA, 95121, Italy (ITA)Analytical testing, Active ingredient (API) manufacture, Packaging3010097713339697390
ZOETIS INC.Registrant: Zoetis Inc200 S GEOSPACE DR, INDEPENDENCE, Missouri (MO) 64056-3338, United States (USA)Labelling, Packaging, Relabelling, Repackaging3007919064079767221
Zoetis LLCRegistrant: Zoetis Inc2605 E. Kilgore Road, Kalamazoo, Michigan (MI) 49001, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging3010146372079995959
ZOETISRegistrant: Zoetis Inc1 Se Pfizer Way, Lees Summit, Missouri (MO) 64081, United States (USA)Labelling, Packaging, Relabelling, Repackaging1922097071419364
Zoetis Services LLCRegistrant: Zoetis Inc1100 NW Main St, Lees Summit, Missouri (MO) 64086, United States (USA)Labelling, Packaging, Relabelling, Repackaging3030978447119241673
Zoetis LLCRegistrant: Zoetis Inc601 West Cornhusker Highway, Lincoln, Nebraska (NE) 68521-3577, United States (USA)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging1910179039055157
Catalogue

Drug listings by form and route

29

29 active NDC listings: 24 drug for further processing, 5 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 19, BULK INGREDIENT 5, EXPORT ONLY 5.

Dosage formNDCs
tablet, chewable15
powder4
tablet3
tablet, coated3
solution2
liquid1
paste1
RouteNDCs
Labeller name on the listingNDCs
zoetis inc.29
Catalogue

Marketed products

29
BrandGeneric nameForm / routeNDC
-Bedinvetmabsolution54771-2782BULK INGREDIENT
-Doramectinpowder54771-0207BULK INGREDIENT
-Doxycyclinepaste54771-5246EXPORT ONLY
-Malic Acid, Benzoic Acid, Salicylic Acidsolution54771-7600DRUG FOR FURTHER PROCESSING
-Moxidectinpowder54771-7016BULK INGREDIENT
-Nutritional Supplementtablet54771-8446EXPORT ONLY
-Nutritional Supplementtablet54771-8448EXPORT ONLY
-Nutritional Supplementtablet54771-8451EXPORT ONLY
-Oclacitinib maleatetablet, coated54771-0495DRUG FOR FURTHER PROCESSING
-Oclacitinib maleatetablet, coated54771-0496DRUG FOR FURTHER PROCESSING
-Oclacitinib maleatetablet, coated54771-0497DRUG FOR FURTHER PROCESSING
-Oclacitinib maleatetablet, chewable54771-1207DRUG FOR FURTHER PROCESSING
-Oclacitinib maleatetablet, chewable54771-1208DRUG FOR FURTHER PROCESSING
-Oclacitinib maleatetablet, chewable54771-1209DRUG FOR FURTHER PROCESSING
-Oclacitinib maleatepowder54771-1344BULK INGREDIENT
-sarolanertablet, chewable54771-1371DRUG FOR FURTHER PROCESSING
-sarolanertablet, chewable54771-1372DRUG FOR FURTHER PROCESSING
-sarolanertablet, chewable54771-1373DRUG FOR FURTHER PROCESSING
-sarolanertablet, chewable54771-1374DRUG FOR FURTHER PROCESSING
-sarolanertablet, chewable54771-1375DRUG FOR FURTHER PROCESSING
-sarolanertablet, chewable54771-1376DRUG FOR FURTHER PROCESSING
-sarolanerpowder54771-2716BULK INGREDIENT
-sarolaner, moxidectin, and pyranteltablet, chewable54771-2667DRUG FOR FURTHER PROCESSING
-sarolaner, moxidectin, and pyranteltablet, chewable54771-2668DRUG FOR FURTHER PROCESSING
-sarolaner, moxidectin, and pyranteltablet, chewable54771-2669DRUG FOR FURTHER PROCESSING
-sarolaner, moxidectin, and pyranteltablet, chewable54771-2670DRUG FOR FURTHER PROCESSING
-sarolaner, moxidectin, and pyranteltablet, chewable54771-2671DRUG FOR FURTHER PROCESSING
-sarolaner, moxidectin, and pyranteltablet, chewable54771-2684DRUG FOR FURTHER PROCESSING
-vitaminsliquid54771-8443EXPORT ONLY
Neighbours

Registered in the same town

5
Compare

Comparable companies in United States

Enquiry

Common questions

Is Zoetis Inc FDA approved?
Zoetis Inc holds 11 FDA-registered establishments across 6 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Zoetis Inc's drugs manufactured?
At registered sites in Australia, Belgium, Spain, Ireland, Italy, the United States. The FDA register lists Rutherford; Ottignies-Louvain-la-Neuve; Bianya; The Copse; Tullamore; CATANIA, and 4 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, particle size reduction, relabelling, repackaging, sterilize.
What drugs does Zoetis Inc make?
29 products are listed under Zoetis Inc in the openFDA NDC Directory, most often as tablet, chewable; powder; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.